Unlocking the potential of antibody–drug conjugates for cancer therapy

JZ Drago, S Modi, S Chandarlapaty - Nature Reviews Clinical …, 2021 - nature.com
… We then propose a path forward by highlighting several hypotheses and novel strategies
to maximize the potential benefit that ADCs can provide to patients with cancer. …

Small-molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer

K McClinch, RA Avelar, D Callejas, S Izadmehr… - Cancer research, 2018 - AACR
… PP2A as a novel strategy for the treatment of prostate cancer. … were adjusted for multiple
hypotheses testing using the p.… been largely ignored for drug development because of their …

A framework for the development of effective anti-metastatic agents

…, Cancer Research UK and Cancer … - Nature Reviews …, 2019 - nature.com
… To assist the cancer drug discovery and development … types of cancer, notably breast and
prostate cancer and melanoma 170 … These studies offer a provocative translational hypothesis, …

Accelerating anticancer drug development—opportunities and trade-offs

SJ Nass, ML Rothenberg, R Pentz, H Hricak… - Nature Reviews …, 2018 - nature.com
… , in the form of novel trial designs or modelling strategies, to … patients with metastatic
castration-resistant prostate cancer … secondary analyses to test prespecified hypotheses can …

Treatment of advanced prostate cancer

MY Teo, DE Rathkopf, P Kantoff - Annual review of medicine, 2019 - annualreviews.org
… -resistant prostate cancer. We review clinical trials and survival benefit for these therapies
and assess how the understanding of the disease shifted as these therapies were developed. …

[HTML][HTML] Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

S Gillessen, G Attard, TM Beer, H Beltran, A Bossi… - European urology, 2018 - Elsevier
… The biological definition of oligometastatic prostate cancer is open to interpretation as is the
entire concept that this is a prognostic and therapeutically distinct subset of patients that falls …

[HTML][HTML] Epidemiology of prostate cancer

P Rawla - World journal of oncology, 2019 - ncbi.nlm.nih.gov
biological mechanism is described as “prostate stagnation hypothesis”, which involves the
prostatic … This information will provide an opportunity for the development of novel targeted …

Screening out irrelevant cell-based models of disease

P Horvath, N Aulner, M Bickle, AM Davies… - … reviews Drug discovery, 2016 - nature.com
… the discovery of many basic biological processes, they often fail to provide an adequate platform
for drug discovery … potential of novel lead compounds and new target hypotheses. ECM, …

Drug repurposing: a promising tool to accelerate the drug discovery process

V Parvathaneni, NS Kulkarni, A Muth, V Gupta - Drug discovery today, 2019 - Elsevier
drug discovery because it provides a novel way to explore old … Hypothesis-driven strategies
for drug repurposing can … Metformin Type II diabetes Advanced prostate cancer Inhibition of …

TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells

F Zhou, S Gao, D Han, W Han, S Chen, S Patalano… - Oncogene, 2019 - nature.com
… To test this hypothesis, we first compared the level of cGMP in … sGC may provide a novel
strategy to treat TMPRSS2-ERG-… calculated based on at least 3 biological repeats. Student’s t-…